Antibody response to four secretory proteins from Mycobacterium tuberculosis and their complex antigen in TB patients

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 12, 2005, Pages 1327-1334

  Wang, Bao Lin ^a   Xu, Y ^a   Li, Z M ^b   Xu, Y M ^a   Weng, X H ^c   Wang, H H ^a  

^a FUDAN UNIVERSITY   (China)

^b Synergy America Inc   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Antibody; Antigen; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN CFP 21; PROTEIN ESAT 6; PROTEIN MPT 63; PROTEIN MPT 64; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 33144466358     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nunn P. The global control of tuberculosis: what are the prospects? Scand J Infect Dis 2001; 33: 329-332.
2. Davies P D. Tuberculosis: the global epidemic. J Indian Med Assoc 2000; 98: 100-102.
3. Schluger N W, Burzynski J. Tuberculosis and HIV infection: epidemiology, immunology, and treatment. HIV Clin Trials 2001; 2: 356-365.
4. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1303.
5. Lalvani A, Pathan A A, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-2021.
6. Daniel T M. Antibody and antigen detection for the immuno-diagnosis of tuberculosis: why not? What more is needed? Where do we stand today? J Infect Dis 1988; 158: 678-680.
7. Ivanyi J, Bothamley G H, Jackett P S. Immunodiagnostic assays for tuberculosis and leprosy. Brit Med Bull 1988; 44: 635-649.
8. Verbon A, Kuijper S, Jansen H M, Speelman P, Kolk A H. Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol 1990; 136: 955-964.
9. Landowski C P, Godfrey H P, Bentley-Hibbert S I, et al. Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J Clin Microbiol 2001; 39: 2418-2424.
10. Weldingh K, Rosenkrands I, Jacobsen S, Rasmussen P B, Elhay M J, Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun 1998; 66: 3492-3500.
11. Sørensen A L, Nagai S, Houen G, Andersen P, Andersen A B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63: 1710-1717.
12. Manca C, Lyashchenko K, Wiker H G, Usai D, Colangeli R, Gennaro M L. Molecular cloning, purification, and serological characterization of MPT-63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997; 65: 16-23.
13. Roche P W, Winter N, Triccas J A, Feng C G, Britton W J. Expression of Mycobacterium tuberculosis MPT-64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol 1996; 103: 226-232.
14. Colangeli R, Heijbel A, Williams A M, et al. Three-step purification of lipopolysaccharide-free, polyhistidine-tagged recombinant antigens of Mycobacterium tuberculosis. J Chromatogr B Biomed Sci Appl 1998; 714: 223-235.
15. Blackwell V C, Hamilton A J, Hay R J. Production of a species specific monoclonal antibody against a 56-kDa Mycobacterium marinum antigen which is potentially useful in culture identification. FEMS Immunol Med Microbiol 2001; 30: 9-12.
16. Andersen P, Ljungqvist L, Haslov K, Bentzon M W, Heron I. Proliferative response to seven affinity purified mycobacterial antigens in eight trains of inbred mice. Int J Lepr Other Mycobact Dis 1991; 59: 58-67.
17. Mahairas G G, Sabo P J, Hickey M J, Singh D C, Stover C K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178: 1274-1282.
18. Harboe M, Oettinger T, Wiker H G, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16-22.
19. Elhay M J, Oettinger T, Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT-64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun 1998; 66: 3454-3456.
20. Wu-Hsieh B A, Chen C K, Chang J H, et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001; 33: 1336-1340.
21. Louise R, Skjot V, Agger E M, Andersen P. Antigen discovery and tuberculosis vaccine development in the post-genomic era. Scand J Infect Dis 2001; 33: 643-647.
22. Harboe M, Malin A S, Dockrell H S, et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 1998; 66: 717-723.
23. Arend S M, Ottenhoff T H, Andersen P, van Dissel J T. Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 680-686.
24. Horwitz M A, Lee B W, Dillon B J, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995; 92: 1530-1534.
25. Nagai S, Wiker H G, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991; 59: 372-382.
26. Oettinger T, Andersen A B. Cloning and B-cell-epitope mapping of MPT-64 from Mycobacterium tuberculosis H37Rv. Infect Immun 1994; 62: 2058-2064.
27. Boom W H, Wallis R S, Chervenak K A. Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect Immun 1991; 59: 2737-2743.
28. Schoel B, Gulle H, Kaufmann S H. Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques. Infect Immun 1992; 60: 1717-1720.
29. Lyashchenko K, Colangeli R, Houde M, Al Jahdali H, Menzies D, Gennaro M L. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998; 66: 3936-3940.
30. van Pinxteren L A, Ravn P, Agger E M, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7: 155-160.